What ethical debates surround the use of three-person DNA in fertility treatments?

Question

Accepted Answer

Ethical Debates Emerge Over Three-Person DNA Fertility Treatment

The recent birth of a baby conceived using genetic material from three individuals, following a controversial fertility treatment, has ignited significant ethical discussions within the medical community. This innovative in vitro fertilisation (IVF) technique, which merges the infertile mother's egg, the father's sperm, and a donor woman's egg, represents a departure from traditional methods. While proponents hail it as a medical revolution enabling women with severe fertility issues or rare mitochondrial diseases to have healthy children with their own genetic material, critics raise concerns about the necessity and potential risks of such procedures.
Concerns Regarding Necessity and Unknown Risks

A primary point of contention revolves around the core methodology of the treatment. Tim Child, a professor at Oxford University and medical director of the Fertility Partnership, has voiced concerns that the necessity of removing the patient's genetic material and transferring it into a donor egg has not been definitively proven. Furthermore, Child highlighted that the full spectrum of risks associated with this technique remains largely unknown. While these risks might be deemed acceptable for treating specific mitochondrial diseases, their application in broader infertility cases, as seen in Greece, is considered by some to be less justifiable given the uncertainties.
Potential for Broader Application and Medical Advancement

Despite the ethical reservations, the developers of the technique, including Dr. Panagiotis Psathas, president of Greece’s Institute of Life, and Dr. Nuno Costa-Borges, emphasize its potential to assist a significant number of women. They posit that this method could offer a solution for women who have experienced multiple IVF failures or carry rare mitochondrial genetic diseases, enabling them to conceive a healthy child using their own genetic material. This perspective frames the treatment as a vital advancement in assisted reproduction, expanding the possibilities for parenthood.
Precedent and Context of the Technique

This groundbreaking application in Greece follows a similar DNA-switching technique employed in Mexico in 2016. In the Mexican case, the procedure was specifically utilised to prevent the transmission of a mother's hereditary illness, Leigh syndrome, to her child. While that instance focused on averting a severe congenital disorder, the Greek case marks the first instance where this three-person DNA IVF technique has been deployed specifically to overcome infertility, allowing a mother who was otherwise unable to conceive to bear a child with her own genetic contribution.

Reading history

Hide →

This history is cleared when the page is closed.

What ethical debates surround the use of three-person DNA in fertility treatments?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends